***Trost Commentary and Key Take-Home Points*** This was a study that we did of men who we treated for PD while at Mayo Clinic. We basically asked all men to complete a questionnaire that included a question as to whether or not the condition caused their partner pain. We then compared differences between men who answered yes or […]
***Trost Commentary and Key Take-Home Points*** This was a summary that Matt, Larry, Giorgio and I worked on to help other physicians better understand the Peyronie’s scientific literature. There are many challenges that come with trying to interpret Peyronie’s studies, and because of this, it is often important to critically evaluate any paper that is
***Trost Commentary and Key Take-Home Points*** This manuscript represents a nice review of outcomes of patients who undergo surgery post Xiaflex treatment. The key finding from the study is that surgery remains a viable option for men who do not experience a sufficient improvement with Xiaflex. I think it’s important to recognize that the key finding from the study should
–Trost Commentary and Key Take-Aways– Shock wave therapy has recently become in vogue as an alternative treatment option for PD. However, patients need to recognize that there really are no consistent data demonstrating any benefits. The American Urological Association and the Sexual Medicine Society of North America both have position statements that indicate that shock
–Trost Commentary and Key Take-home Points– This current study highlights how common issues such as indentations, hourglass deformities, or other similar findings are among men with Peyronie’s Disease. These types of deformities can be particularly bothersome for individuals as they may cause buckling, instability, or anxiety for men during penetrative intercourse (i.e. fear of instability
—Dr. Trost Commentary and Key Take Home Points— This current study evaluates the use of two different injection treatments for men with early phase Peyronie’s Disease. This study was performed by an experienced group of researchers in Italy. This is important to recognize though, as the gold-standard injection treatment (Xiaflex) is more difficult to use
The annual meeting of the Sexual Medicine Society of North America concluded on 10/27/2019. This is the largest and most respected sexual medicine society in North America and includes the greatest authorities on sexual medicine. There were several abstract that were presented at the meeting that relate to Peyronie’s Disease, and our objective with this
Summary of Key Studies from the Sexual Medicine Society Annual Meeting Read More »
—Dr. Trost Commentary and Key Take Home Points — The current study evaluates the combination of traction therapy and oral treatments for Peyronie’s Disease (pentoxifylline and colchicine). Dr. Carrier is a well-known Andrologist with significant experience in Peyronie’s Disease (and is a great person as well). This particular study adds value to the concept of using combination therapies for managing Peyronie’s Disease. There are a few key
—Dr. Trost Commentary and Key Take-home Points— This is a great proof of concept study and goes directly after one of the mechanisms that is thought to contribute to Peyronie’s Disease. The challenge with a therapy such as this, though, is that often, men are not even aware of the condition until the fibrotic tissue has already
Summary of "Verteporfin as a Medical Treatment in Peyronie’s Disease" Read More »
—Dr. Trost Commentary and Key Take-home Points— Although relatively uncommon, penile implant infections represent a challenging and potentially devastating complication of penile prosthesis surgery. Revision surgery after prior infections can increase the level of difficulty and risk of intra- and post-operative complications. In the current study, the authors proposed a possible mechanism to reduce the